Open AccessSafety Outcomes During Pediatric GH Therapy: Final Results From the Prospective GeNeSIS Observational Program
Author(s) -
Christopher J. Child,
Alan G. Zimmermann,
George P. Chrousos,
Elizabeth A. Cummings,
Cheri Deal,
Tomonobu Hasegawa,
Nan Jia,
Sarah Lawrence,
Agnès Linglart,
Sandro Loche,
Mohamad Maghnie,
Jacobo Pérez,
Michel Polak,
Barbara Predieri,
Annette Richter-Unruh,
Ron G. Rosenfeld,
Diego Yeste,
Tohru Yorifuji,
Werner Blum
Publication year - 2018
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2018-01189
Subject(s) - medicine , pediatrics , population , incidence (geometry) , short stature , cancer , diabetes mellitus , observational study , endocrinology , physics , environmental health , optics
Safety concerns have been raised regarding premature mortality, diabetes, neoplasia, and cerebrovascular disease in association with GH therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom